A study published in the journal Clinical Infectious Diseases actually found that not only did the inactivated influenza vaccine not provide additional protection against the flu virus, but it also left recipients lacking in “temporary non-specific immunity that protected against other respiratory viruses.” (Related: Flu vaccine BOMBSHELL: 630% more “aerosolized flu virus particles” emitted by people who received flu shots… flu vaccines actually SPREAD the flu.)
So, not only is the flu shot ineffective, but it increases risk of other viral infections. It is also known to carry serious side effects, including seizures and convulsions, swelling on the brain and Guillain-Barre syndrome, to name a few. (Related: Flu vaccine paradox spreading globally as more vaccinated people catch the flu.) READ MORE…
Depression is on the rise around the world and, according to one author, the World Health Organization (WHO) has stated that approximately 300 million people worldwide suffer from this debilitating disorder
Author, Amy Morin, LCSW, wrote in her article, Depression Statistics Everyone Should Know, that in the United States alone, 16.2 million adults have experienced a major depressive episode in the past year.
Dr.Kelly Brogan’s paper outlined the strong possibility that the aluminum adjuvant that is currently being used in at least 18 childhood vaccinations may be responsible for the increase in long-term brain inflammation, neurological complications and autoimmunity. She stated that:
“One of the most relevant aluminum-containing vaccines is Gardasil, responsible for more than 34000 reported adverse events,and now Gardasil 9, which contains twice the aluminum dose (ie, now with 500 μg per 3 recommended doses).”
CDC: “It takes a long time for a cVDPV to occur. Generally, the strain will have been allowed to circulate in an un- or under-immunized population for a period of at least 12 months”. (Oh sure!….more vaccines for the fictitious claim of “herd immunity”)
The World Health Organization convened a meeting in May 2012 to review the understanding of Vaccine Derived Polio Virus (VDPV) emergence and transmission. Several key points that were reaffirmed are as follows: 1) the clinical signs and severity of paralysis associated with Vaccine Derived Polo Virus (VDPV) and the Wild Polio Virus (WPV) infections are indistinguishable; 2) cVDPVs pose the same public health threat as WPVs and require the same control measures;
Polio Vaccine: Paralysis due to Polio Vaccine – 50,000 persons in India
Three years ago, a groundbreaking study published in the journal Clinical Infectious Diseases, whose authorship included scientists working for the Bureau of Immunization, New York City Department of Health and Mental Hygiene, and the National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, looked at evidence from the 2011 New York measles outbreak that individuals with prior evidence of measles vaccination and vaccine immunity were both capable of being infected with measles and infecting others with it (secondary transmission).
There are also indications that the Al adjuvants in vaccines could be
causally associated with the symptoms used to diagnose ASD
(Tomljenovic and Shaw, 2011; Shaw and Tomljenovic, 2013; Miller,
2016). Thus, a recent study reported a positive correlation between the
levels of the toxic metals including Al and the severity of the ASD
symptoms as assessed by using the Childhood Autism Rating Scale
(CARS) (Metwally et al., 2015). According to numerous studies, the
interaction of Al in ASD patients was attributed to suppression of cellular
energy synthesis and elevation of the potential neurotoxic activities
in ASD children.
It has been proposed that Al exposure may contribute as an environmental
factor to cause ASD when taken in its elemental or salt
form via oral ingestion and/or as adjuvant (Morris et al., 2017). Numerous
studies highlight the relevance of Al exposure and development
of ASD (Table 1). For example, Shaw and Tomljenovic (2013) have
reported the potential involvement of Al adjuvants in the development
of ASD. They found the prevalence of ASD in areas where exposure to
vaccine-derived Al is high. READ STUDY: Toxic metal pollution and ASD. Environmental Research 2018
VLA Comment: Aluminum adjuvants are used in vaccines such as hepatitis A, hepatitis B, diphtheria–tetanus-containing vaccines, Haemophilus influenzae type b, and pneumococcal vaccines, but they are not used in the live, viral vaccines, such as measles, mumps, rubella, varicella and rotavirus.
ABSTRACT
EXCERPTS
The present review summarizes data on neurological adverse events following vaccination in the relation to intensity, time of onset, taking into account the immunological and non-immunological mechanisms. The authors described the physio-logical development of the immune system and the possible immune system responses following vaccination. Toxic property of Thimerosal – a mercury-containing preservative used in some vaccines was presented. The neurological complications after vaccination were described. The role of vaccination in the natural course of infectious diseases and the current immunizations schedule in Poland was discussed.
Excerpts: Despite the assurances of the necessity and safety of vaccinations, there are more and more questions and doubts, which both physicians and parents are waiting to be clarified.
According to the author, on account of the existing maternal antibodies, vaccination against certain microorganisms administered shortly after birth does not lead to long-lasting immunity. It should be emphasized that the immune system reaches full immunoregulatory and defensive maturity at about 3 years of age [19].
European countries, where the vaccination of neonates was abandoned and a ban on the use of thimerosal in vaccines were introduced [4, 74]. Note also that Scandinavian countries have the lowest rates of autism compared to other developed countries in which children are vaccinated much earlier and with greater number of vaccines [49]. Read study: prog-health-sci-2012-vol-2-no1-neurologic-adverse-events-vaccination
Click to enlarge 